|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 17 Nov 2023 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.4 H | 4.8 - 5.7 | % |
| Glucose [Mass/volume] in Blood | 70.9 | 70 - 99 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 19.2 | 7 - 50 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.9 | 0.6 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 8.9 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 141.3 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.9 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 106.1 | 98 - 114 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 28.5 | 22 - 32 | mmol/L |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows a persistently elevated HbA1c (now 6.4%), indicating poor glycemic control and likely diabetes. Other parameters, including renal function, electrolytes, and calcium, are within normal limits. No acute metabolic or renal disturbances are evident. Recommend clinical follow-up for diabetes management and monitoring of glycemic control. |